Eben Tessari Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

Eben Tessari is CHIEF OPERATING OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 77,953 shares of KNSA, which is worth approximately $1.8 Million. The most recent transaction as insider was on Mar 16, 2025, when has been sold 577 shares (Class A Ordinary Share) at a price of $22.61 per share, resulting in proceeds of $13,045. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 78K

18.78% 3M change

36.54% 12M change

Total Value Held $1.8 Million

Eben Tessari Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 16 2025	SELL Payment of exercise price or tax liability	$13,045 $22.61 p/Share	577 Reduced 0.73%	77,953 Class A Ordinary Share
Mar 16 2025	BUY Exercise of conversion of derivative security	-	1,964 Added 2.44%	78,530 Class A Ordinary Share
Mar 10 2025	SELL Open market or private sale	$261,333 $21.06 p/Share	12,409 Reduced 13.95%	76,566 Class A Ordinary Share
Mar 10 2025	BUY Exercise of conversion of derivative security	$26,600 $3.8 p/Share	7,000 Added 7.29%	88,975 Class A Ordinary Share
Feb 10 2025	SELL Open market or private sale	$273,980 $19.57 p/Share	14,000 Reduced 14.59%	81,975 Class A Ordinary Share
Feb 10 2025	BUY Exercise of conversion of derivative security	$26,600 $3.8 p/Share	7,000 Added 6.8%	95,975 Class A Ordinary Share
Jan 13 2025	SELL Open market or private sale	$260,540 $18.61 p/Share	14,000 Reduced 13.6%	88,975 Class A Ordinary Share
Jan 13 2025	BUY Exercise of conversion of derivative security	$26,600 $3.8 p/Share	7,000 Added 6.37%	102,975 Class A Ordinary Share
Dec 16 2024	SELL Open market or private sale	$470,467 $20.44 p/Share	23,017 Reduced 19.34%	95,975 Class A Ordinary Share
Dec 16 2024	BUY Exercise of conversion of derivative security	$25,467 $1.59 p/Share	16,017 Added 11.86%	118,992 Class A Ordinary Share
Nov 18 2024	SELL Open market or private sale	$357,680 $21.04 p/Share	17,000 Reduced 14.17%	102,975 Class A Ordinary Share
Nov 18 2024	BUY Exercise of conversion of derivative security	$15,900 $1.59 p/Share	10,000 Added 7.69%	119,975 Class A Ordinary Share
Oct 15 2024	SELL Open market or private sale	$456,790 $26.87 p/Share	17,000 Reduced 13.39%	109,975 Class A Ordinary Share
Oct 15 2024	BUY Exercise of conversion of derivative security	$15,900 $1.59 p/Share	10,000 Added 7.3%	126,975 Class A Ordinary Share
Sep 23 2024	SELL Open market or private sale	$437,325 $24.99 p/Share	17,500 Reduced 13.01%	116,975 Class A Ordinary Share
Sep 23 2024	BUY Exercise of conversion of derivative security	$15,900 $1.59 p/Share	10,000 Added 6.92%	134,475 Class A Ordinary Share
Sep 02 2024	SELL Payment of exercise price or tax liability	$15,428 $26.74 p/Share	577 Reduced 0.46%	124,475 Class A Ordinary Share
Sep 02 2024	BUY Exercise of conversion of derivative security	-	1,964 Added 1.55%	125,052 Class A Ordinary Share
Sep 01 2024	SELL Payment of exercise price or tax liability	$35,350 $26.74 p/Share	1,322 Reduced 1.06%	123,088 Class A Ordinary Share
Sep 01 2024	BUY Exercise of conversion of derivative security	-	4,499 Added 3.49%	124,410 Class A Ordinary Share
Aug 27 2024	SELL Open market or private sale	$470,925 $26.91 p/Share	17,500 Reduced 12.74%	119,911 Class A Ordinary Share
Aug 27 2024	BUY Exercise of conversion of derivative security	$15,900 $1.59 p/Share	10,000 Added 6.78%	137,411 Class A Ordinary Share
Apr 08 2024	SELL Payment of exercise price or tax liability	$14,337 $17.9 p/Share	801 Reduced 0.63%	126,024 Class A Common Share
Apr 08 2024	BUY Exercise of conversion of derivative security	-	2,726 Added 2.1%	126,825 Class A Common Share
Apr 01 2024	SELL Payment of exercise price or tax liability	$10,263 $19.7 p/Share	521 Reduced 0.42%	124,099 Class A Common Share

Eben Tessari

CHIEF OPERATING OFFICER

Hamilton, D0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Value

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA

Account